Skip to main content

Table 1 Correlation of CEACAM 7 and CEA expression with clinicopathological characteristics of gastric carcinoma.

From: Dynamic expression of CEACAM7 in precursor lesions of gastric carcinoma and its prognostic value in combination with CEA

Variables

CEACAM 7

P value

CEA

P value

 

Negative

(n = 100)

Positive

(n = 45)

 

Negative

(n = 81)

Positive

(n = 64)

 

Gender

      

Male

74(67.3%)

36(32.7%)

0.437

58(52.7%)

52(47.3%)

0.178

Female

26(74.3%)

9 (25.7%)

 

23(65.7%)

12(34.3%)

 

Age (Years)

      

(means ± SD)

59.8 ± 10.4

58.1 ± 13.3

0.608

60.3 ± 9.4

58.9 ± 12.9

0.512

Location of tumor

      

Upper

12(60.0%)

8 (40.0%)

0.601

9 (45.0%)

11(55.0%)

0.544

Middle

49(69.0%)

22(31.0%)

 

40(56.3%)

31(43.7%)

 

Lower

39(72.2%)

15(27.8%)

 

32(59.3%)

22(40.7%)

 

Histology †

      

Well and Moderate

56(80.0%)

14(20.0%)

0.006

43(61.4%)

27(38.6%)

0.741

Undifferentiated

44(58.7%)

31(41.3%)

 

38(50.7%)

37(49.3%)

 

Lauren's classification

      

Intestinal

56(77.8%)

16(22.2%)

0.023

39(54.2%)

33(45.8%)

0.683

Diffuse

44(60.3%)

29(39.7%)

 

42(57.5%)

31(42.5%)

 

Depth of tumor

      

T1-T2

28(75.7%)

9 (24.3%)

0.307

20(54.1%)

17(45.9%)

0.797

T3-T4

72(66.7%)

36(33.3%)

 

61(56.5%)

47(43.5%)

 

Node metastasis

      

Negative

59(72.8%)

22(27.2%)

0.257

37(67.3%)

18(32.7%)

0.031

Positive

41(64.1%)

23(35.9%)

 

44(48.9%)

46(51.1%)

 

Lymphatic invasion

      

Negative

44(75.9%)

14(24.1%)

0.143

35(60.3%)

23(39.7%)

0.375

Positive

56(64.4%)

31(35.6%)

 

46(52.9%)

41(47.1%)

 

Venous invasion

      

Negative

52(70.3%)

22(29.7%)

0.729

43(58.1%)

31(41.9%)

0.578

Positive

48(67.6%)

23(32.4%)

 

38(53.5%)

33(46.5%)

 

Tumor Stage

      

I- II

40(62.5%)

24(37.5%)

0.135

34(53.1%)

30(46.9%)

0.555

III- IV

60(74.1%)

21(25.9%)

 

47(58.0%)

34(42.0%)

 
  1. NOTE: Pearson's X2 test was done to get P value except that Ages was compared by Student-T test. †Well = well differentiated carcinoma; moderately = moderately differentiated carcinoma; undifferentiated = poorly differentiated carcinoma, signet ring cell carcinoma, or mucinous carcinoma.